Banque Cantonale Vaudoise
ALLO icon

Banque Cantonale Vaudoise’s Allogene Therapeutics ALLO Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$136K Buy
+85,224
New +$162K ﹤0.01% 667

Other funds holding ALLO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Pfizer
Pfizer New York $164M AUM 53.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Banque Cantonale Vaudoise's ALLO Position: Q3 2026 in Review

Banque Cantonale Vaudoise opened a new position in Allogene Therapeutics (ALLO) in Q3 2026: 85,224 shares worth $136K. The stake represents ﹤0.01% of the portfolio and ranks #667 among its holdings.

141 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.

  • Banque Cantonale Vaudoise held 85,224 shares of Allogene Therapeutics worth $136K as of Q3 2026.
  • Allogene Therapeutics was a new Banque Cantonale Vaudoise position in Q3 2026.
  • Allogene Therapeutics made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q3 2026, its #667 holding.
  • 141 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2026, filed 12 Nov 2026.